Aliza Thompson

Company: FDA

Job title: Acting Director, Division of Cardiology and Nephrology

Seminars:

Fireside Chat: Navigating the Multi-Drug Treatment Landscape in CKD: Understanding the Implications on Drug Discovery & Development to Inform Future Directions 8:00 am

As the chronic kidney disease treatment landscape evolves, marked by significant breakthroughs such as SGLT2i, GLP-1s, ACEi/ARBs, MRAs, the field is rapidly advancing toward more effective multi-drug therapies. However, these advancements present new challenges and considerations for drug discovery, development, and clinical trial design. This panel will explore the complexities of leveraging these successes to…Read more

day: Day One AM

Revolutionizing FSGS: Addressing Proteinuria & GFR as Clinical Endpoints in FSGS Through the PARASOL Initiative 11:30 am

Explore the current challenges in identifying reliable, meaningful endpoints in FSGS clinical trials, and how the PARASOL initiative seeks to establish the relationship between short-term biomarker changes (proteinuria and GFR) and long-term outcomes Exploring how global patient registries and real-world data from diverse cohorts are informing endpoint identification, particularly in rare diseases like FSGS where…Read more

day: Pre-Conference Focus Day